tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

JOINN Laboratories Expands Investment in ICBC Wealth Management Products

Story Highlights
JOINN Laboratories Expands Investment in ICBC Wealth Management Products

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

JOINN Laboratories (China) Co., Ltd. Class H ( (HK:6127) ) has shared an announcement.

JOINN Laboratories has announced a new investment in ICBC wealth management products totaling RMB40,000,000, increasing its total investment in these products to RMB410,000,000. This transaction, now classified as a discloseable transaction under the Hong Kong Stock Exchange Listing Rules, reflects the company’s strategic financial management and investment approach, potentially impacting its financial positioning and stakeholder interests.

The most recent analyst rating on (HK:6127) stock is a Hold with a HK$14.30 price target. To see the full list of analyst forecasts on JOINN Laboratories (China) Co., Ltd. Class H stock, see the HK:6127 Stock Forecast page.

More about JOINN Laboratories (China) Co., Ltd. Class H

JOINN Laboratories (China) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the financial sector with a focus on investments in wealth management products.

Average Trading Volume: 8,648,844

Technical Sentiment Signal: Buy

Current Market Cap: HK$30.79B

See more insights into 6127 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1